Sort
17,054 grants matching “genome editing”
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs
$555,144Joseph C Wu · Stanford University · R01 · FY2018 · HL
Dynamic Nuclear Polarization MR Spectroscopic Imaging for Diagnosis and Treatment Response Assessment in Hepatocellular Carcinoma
$555,123Terence P Gade · University Of Pennsylvania · R01 · FY2023 · CA
Altered Sensibility Following Peripheral Nerve Damage
$554,916Clifford J Woolf · Boston Children'S Hospital · R01 · FY2017 · NS
Targeted correction of the human CFTR gene
$554,851Marie E Egan · Yale University · R01 · FY2016 · HL
Targeted correction of the human CFTR gene
$554,851Marie E Egan · Yale University · R01 · FY2017 · HL
Targeted correction of the human CFTR gene
$554,851Marie E Egan · Yale University · R01 · FY2015 · HL
SPP1, Oxidative Stress, and Lead Toxicity
$554,785Quan Lu · Harvard School Of Public Health · R01 · FY2021 · ES
Sex divergence and cell specificity of age-related hippocampal DNA modifications
$554,739Willard M Freeman · Oklahoma Medical Research Foundation · R01 · FY2021 · AG
Huntington's disease repeat instability and pathogenesis
$554,553Vanessa C Wheeler · Massachusetts General Hospital · R01 · FY2018 · NS
Huntington's disease repeat instability and pathogenesis
$554,553Vanessa C Wheeler · Massachusetts General Hospital · R01 · FY2019 · NS
Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer
$554,502Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2020 · CA
DEVELOPMENT OF AAV-CRISPR/CAS9-BASED THERAPIES FOR CONE ROD DYSTROPHY
$554,460Shannon Elizabeth Boye · University Of Florida · R01 · FY2020 · EY
A Quantitative Multiplexed Platform for the Pharmacogenomic Analysis of Lung Cancer
$554,387Monte Meier Winslow · Stanford University · R01 · FY2016 · CA
A Quantitative Multiplexed Platform for the Pharmacogenomic Analysis of Lung Cancer
$554,387Monte Meier Winslow · Stanford University · R01 · FY2017 · CA
A Quantitative Multiplexed Platform for the Pharmacogenomic Analysis of Lung Cancer
$554,387Monte Meier Winslow · Stanford University · R01 · FY2018 · CA
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
$554,253Daniel H Geschwind · Icahn School Of Medicine At Mount Sinai · U54 · FY2023 · NS
RNAi Screening in Hematopoietic Cells
$554,213Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Genetic basis of nicotine withdrawal in a reduced complexity cross
$554,190Mohamad Imad Damaj · Virginia Commonwealth University · U01 · FY2021 · DA
Genetic basis of nicotine withdrawal in a reduced complexity cross
$554,190Mohamad Imad Damaj · Virginia Commonwealth University · U01 · FY2022 · DA
MicroRNA-10a in Airway Smooth Muscle and Asthma
$554,036Quan Lu · Harvard School Of Public Health · R01 · FY2020 · HL
Project 2
$554,018Paolo Provenzano · University Of Minnesota · P01 · FY2025 · CA
Project 2
$554,018Paolo Provenzano · University Of Minnesota · P01 · FY2021 · CA
The Investigation of disease causing genes in C. elegans
$553,987Andy Golden · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
SPP1, Oxidative Stress, and Lead Toxicity
$553,981Quan Lu · Harvard School Of Public Health · R01 · FY2019 · ES
(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL
$553,684Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2016 · CA